ETH Zurich FemTech Summit
The Summit will be divided into four panels:
On May 26th:
Tracking to bridge the data gap: The gender data gap is a deadly one. Discover innovative ways companies are collecting gender specific medical data to close the gap and better understand female specific metrics through menstrual patterns, remote neonatal monitoring, and analysis of saliva for contraception and fertility.
Innovative Screening + Symptom Monitoring: Disease can be mitigated when caught at the onset. A deep dive with companies focussed on STDs, post partum, cervical cancer and breast cancer who are bringing screening capabilities to the patient.
On May 27th:
The Personalization of contraception + fertility: The field of fertility and contraception have long been opaque and difficult to navigate. Medicine as a whole, however, is entering an era of personalization – explore in what ways personalized medicine holds the promise of revolutionizing female contraception and fertility.
The Future of gynecological pain + symptom management : Examine technologies being put forth to treat the gynecological conditions that affect tens of millions of the world’s women:from pre-empting menopausal symptoms, to tracking endometriosis, and treating symptoms with cannabinoids.
Explore cutting edge research, innovation and inventions from Start Ups and Academics in the field.
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
